Cumulative risk of diabetic foot complications in risk groups of type 1 and type 2 diabetes: Real‐world evidence from a 22‐year follow‐up study

Authors:

Abstract
No abstract available
Funding Information
  • European Association for the Study of Diabetes
  • Novo Nordisk Fonden (no. NNF17SA0031406, no. NNF22OC0076725, no. NNF23OC0084081)

This publication has 9 references indexed in Scilit: